Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raul C Braylan

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of Allergy and Clinical Immunology|October 5, 2016
Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CDAlina E Dulau Florea, Raul C Braylan, Kristian T Schafernak, et al.
Blood|November 1, 2014
GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemiaKarthik A Ganapathi, Danielle M Townsley, Amy P Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2020
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell LeukemiaDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2015
Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individualsJairo M Montezuma-Rusca, Susan Moir, Lela Kardava, et al.
Blood Advances|October 4, 2021
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variantDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2015
Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II StudyCarsten U Niemann, Sarah E M Herman, Irina Maric, et al.
Blood|February 2, 2024
Venous and arterial thrombosis in patients with VEXAS syndromeYael Kusne, Atefeh Ghorbanzadeh, Alina Dulau-Florea, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Allergy and Clinical Immunology|October 5, 2016
Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CDAlina E Dulau Florea, Raul C Braylan, Kristian T Schafernak, et al.
Blood|November 1, 2014
GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemiaKarthik A Ganapathi, Danielle M Townsley, Amy P Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2020
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell LeukemiaDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2015
Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individualsJairo M Montezuma-Rusca, Susan Moir, Lela Kardava, et al.
Blood Advances|October 4, 2021
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variantDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2015
Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II StudyCarsten U Niemann, Sarah E M Herman, Irina Maric, et al.
Blood|February 2, 2024
Venous and arterial thrombosis in patients with VEXAS syndromeYael Kusne, Atefeh Ghorbanzadeh, Alina Dulau-Florea, et al.
Pageof 3